The new-look algorithm, trained and validated with data from more than 25,000 patients, scans a patient's electronic health record and identifies signs of trouble. 

Short-term mortality, however, does not appear to change when TAVR patients present with active cancer. 

While it is not as well-known as some other heart-healthy diets, the portfolio diet is linked to key cardiovascular benefits. "We need to get the word out," one dietitian said. 

The American Heart Association has developed an updated strategy for the prevention and management of cardiovascular disease. A newly defined health condition, cardiovascular-kidney-metabolic syndrome, sits at the center of that strategy. 

“Given the dramatic difference in death risk for older adults receiving complex PCI, we suggest that such interventions in this exceptionally vulnerable population should be approached with additional caution," researchers wrote. 

The two anticoagulants are associated with similar mortality rates. However, a new meta-analysis in Circulation may have cardiologists favoring bivalirudin over heparin. 

According to a new analysis of more than 280,000 deaths, the number of obesity-related cardiovascular deaths in the United States tripled from 1999 to 2020. 

Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.